Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease

Nombre investigadores: Nathan Boliaki, Guillaume Henin, Georgia Bale, Nicolas Lanthier